Search

everythinglearnresearchcommunity

for

Search:↓

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.

Follicular Cell Implantation might become a new treatment for hair loss and could lead to advances in organ regeneration.

Drinking alcohol before taking flibanserin does not increase the risk of severe low blood pressure or fainting.

Minoxidil boosts hair growth by opening potassium channels and increasing cell activity.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Finasteride harms invertebrates' survival and burial ability.

Hair loss affects quality of life, self-esteem, and confidence, but younger patients cope better.

The study found that the enzyme linked to acne is present in the same areas of both acne-affected and normal skin.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

People with androgenetic alopecia often experience high stress, but the stress doesn't affect how the disease progresses or how well different treatments work.

SOD1 and KL are promising targets for new hair loss treatments.

The document's conclusion cannot be determined from the provided text.

Trichoscopy, a hair loss evaluation technique, found that people with Androgenetic Alopecia have more thin hairs, yellow dots, and perifollicular discoloration than healthy individuals.

Men with male pattern baldness don't necessarily have high levels of Dehydroepyandrosterone-sulfate, and there's no link between its levels and the severity of hair loss.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Systemic cyproterone acetate and 5% topical minoxidil are effective and safe for treating female pattern hair loss.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.

Platelet-rich plasma therapy helps increase hair density in male patients with hair loss but doesn't change hair thickness.

Hormone levels in hair change during pregnancy, with progesterone increasing significantly compared to non-pregnant women.

Bioengineering can potentially treat hair loss by regenerating hair follicles and cloning hair, but the process is complex and needs more research.

A new mutation in the Hairless gene causes hair loss in two Pakistani families.

Altering SSAT affects fat metabolism and body fat in mice.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.